Adapthealth Corp (AHCO) is now in the Undervalued zone, suggesting that its current forward PE ratio of 11.26 is considered Undervalued compared with the five-year average of 13.86. The fair price of Adapthealth Corp (AHCO) is between 12.06 to 18.92 according to relative valuation method. Compared to the current price of 9.64 USD , Adapthealth Corp By Undervalued By 20.09%.

Relative Value

Fair Zone

12.06-18.92

Current Price：9.64

20.09%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Adapthealth Corp (AHCO) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Adapthealth Corp (AHCO) has a current Price-to-Book (P/B) ratio of 0.79. Compared to its 3-year average P/B ratio of 0.79, the current P/B ratio is approximately 0.43% higher. Relative to its 5-year average P/B ratio of 1.16, the current P/B ratio is about -31.81% higher. Adapthealth Corp (AHCO) has a Forward Free Cash Flow (FCF) yield of approximately 16.64%. Compared to its 3-year average FCF yield of 11.22%, the current FCF yield is approximately 48.32% lower. Relative to its 5-year average FCF yield of 7.60%, the current FCF yield is about 118.81% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for AHCO competitors is 1.19, providing a benchmark for relative valuation. Adapthealth Corp Corp (AHCO.O) exhibits a P/S ratio of 0.38, which is -67.89% above the industry average. Given its robust revenue growth of -1.21%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of AHCO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of AHCO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is AHCO currently overvalued or undervalued?

What is Adapthealth Corp (AHCO) fair value?

AHCO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Adapthealth Corp (AHCO) is between 12.06 to 18.92 according to relative valuation method.

How does AHCO's valuation metrics compare to the industry average?

The average P/S ratio for AHCO's competitors is 1.19, providing a benchmark for relative valuation. Adapthealth Corp Corp (AHCO) exhibits a P/S ratio of 0.38, which is -67.89% above the industry average. Given its robust revenue growth of -1.21%, this premium appears unsustainable.

What is the current P/B ratio for Adapthealth Corp (AHCO) as of Mar 02 2026?

As of Mar 02 2026, Adapthealth Corp (AHCO) has a P/B ratio of 0.79. This indicates that the market values AHCO at 0.79 times its book value.

What is the current FCF Yield for Adapthealth Corp (AHCO) as of Mar 02 2026?

As of Mar 02 2026, Adapthealth Corp (AHCO) has a FCF Yield of 16.64%. This means that for every dollar of Adapthealth Corp's market capitalization, the company generates 16.64 cents in free cash flow.

What is the current Forward P/E ratio for Adapthealth Corp (AHCO) as of Mar 02 2026?

As of Mar 02 2026, Adapthealth Corp (AHCO) has a Forward P/E ratio of 11.26. This means the market is willing to pay $11.26 for every dollar of Adapthealth Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Adapthealth Corp (AHCO) as of Mar 02 2026?

As of Mar 02 2026, Adapthealth Corp (AHCO) has a Forward P/S ratio of 0.38. This means the market is valuing AHCO at $0.38 for every dollar of expected revenue over the next 12 months.

AHCO Valuation